Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 180 results for "orchid pharma"

Orchid Pharma surges over 13% after receiving USFDA's inspection report
DNA

Buy Orchid Pharma with a target of Rs 48: Mitesh Thacker

In a chat with , Mitesh Thacker of miteshthacker.com, says buy Orchid Pharma Ltd with a target of Rs 48 and a stop loss of Rs 40.90 ET Now: What is your recommendation? Mitesh Thacker: Orchid Pharma is a 'BUY' call with a target of Rs 48 and a ... Economic Times, 1 month ago
[x]  

8 images for orchid pharma

Business Standard India, 1 month ago
Money Control, 1 month ago
Financial Express, 1 month ago
DNA, 1 month ago
India Infoline, 1 month ago
Economic Times, 1 month ago
Financial Express, 1 month ago
Hindu Business Line, 1 month ago
India Infoline

Orchid Pharma shares surge 11% on successful inspection report from USFDA for TN facility

Orchid Pharma shares advanced as much as 13 per cent after it informed bourses that the company has received the Establishment Inspection Report (EIR) from US Food and Drug Administration (Reuters) Orchid Pharma shares advanced as much as 13 per ...
 Financial Express1 month ago Pharmaceutical Newsletter - April 11 to  India Infoline1 month ago Sun Pharma, Psyco Remedies settle trademark litigation and other top pharma news  India Infoline1 month ago Orchid receives FDA nod for Rasagiline generic formulation...  Bio Spectrum Asia1 month ago
[x]  
Business Line

Orchid Pharma, DLF among 12 stocks hogging limelight in Monday'strade

The Sensex recovered over 115 points in early session on Monday on fresh spell of buying in select bluechip stocks amid mixed Asian cues. At 11.10 am, Sensex was trading 13.16 points down at 24,660.68, while NSE Nifty was trading 1.15 points down at ...
 Yahoo! India1 month ago Stocks in focus: Bharti Airtel, Orchid Pharma, Sun Pharma, DLF, Rupa  Business Line1 month ago Orchid Pharma, DLF among 10 stocks that remained in focus in Monday's trade  Financial Express1 month ago
India Infoline

Orchid Pharma informs about company updates

A dedicated place to get a comprehensive economic update, Interactive tools and to voice your opinions. News pertaining to Markets, Corporates, Industry, Economy, Mutual Fund and Business RBI Policy Indicators, Exchange Rates and General ...
 Finalaya.com1 month ago Orchid Pharma receives EIR from US FDA for Kancheepuram facility  India Infoline1 month ago Orchid Pharma receives EIR for Tamil Nadu plant  MyIris1 month ago
[x]  
Money Control

Orchid Pharma gets final nod from USFDA for Parkinson's drug

CHENNAI: The shares of Chennai-based drugmaker Orchid Pharma Ltd have jumped over 13% in mid-day trade after the company announced its drug for Parkinson's Disease has been approved by the US Food and Drug Administration in what it says is a ...
 Economic Times2 months ago Orchid gets final nod from USFDA for Parkinson's drug  Money Control2 months ago
[x]  

Orchid Pharma Ltd to consider quarterly results on May 27, 2016

A meeting of the Board of Directors of Orchid Pharma Ltd is proposed to be held on May 27, 2016, to approve the Audited financial results of the Company for the period from April 01, 2015 to March 31, 2016. As required under the SEBI (Prohibition ...
 Equity Bulls2 days ago Orchid Pharma to hold board meeting  Business Standard1 week ago Orchid Pharma's board meeting on May 27, 2016  Money Control1 week ago

Stocks in news: Sun Pharma, SBI, RPG Life, BPCL, USL, Jet Air

Here are stocks that are in news today: Results today: SBI, HPCL, IOC, Oil India, DLF, NMDC, Sun TV, Tata Communications, REC, Crompton Greaves, Punj Lloyd, Canara Bank, BHEL, BEML, Bharat Electronics, Bombay Dyeing, S H Kelkar and Company, IOB, ...
 Moneycontrol.com2 hours ago

Baxter emerges frontrunner to buy KKR-backed Gland Pharma for $1.1-1.2 billion

MUMBAI: US pharma major Baxter has emerged as the frontrunner to buy Gland Pharma, a KKR backed drug maker, for over a billion dollars as global supply constraints have heightened strategic interests to acquire businesses that focus oninjectables -- ...
 Economic Times2 weeks ago Baxter emerges as frontrunner to buy KKR-backed Gland Pharma for $1.1-1.2 billion [Qatar Tribune]  Pharmacy Choice2 weeks ago

Sun Pharmas Novartis deal could be a bright spot [tayyar.org (Lebanon)]

Sun Pharma's acquisition of 14 established prescription brands of Swiss drug maker Novartis in Japan will give it a head start in the $73 billion brand-conscious market but experts noted the company is likely to face challenges like periodic cuts in ...
 Pharmacy Choice1 month ago Sun Pharma's Novartis deal could be a bright spot  Economic Times1 month ago Sun Pharma’s Novartis deal could be a bright spot  Economic Times1 month ago

Pharmaceutical Newsletter - March 14 to

Top News Corex...Delhi High Court grants relief to Pfizer The Delhi High Court on Monday stayed a Government notification that had banned the manufacture and sale of Pfizer's popular cough syrup Corex, and also directed the Centre not to take ...
 India Infoline2 months ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less